| Theme |
Heart and it's Diseases in Dialysis Patients -- For their better longevity |
| Title |
Coronary angiography and interventional treatment for hemodialysis patients with coronary artery disease |
| Author |
Yuri Tanaka |
Division of Nephrology, Toho University Ohashi Medical Center |
| Author |
Nobuhiko Joki |
Division of Nephrology, Toho University Ohashi Medical Center |
| Author |
Hiroki Hase |
Division of Nephrology, Toho University Ohashi Medical Center |
| [ Summary ] |
It has been noted that coronary artery disease (CAD), which exists at the initiation of dialysis, is closely associated with a high frequency of major adverse cardiac events (MACE) in the early phases of maintenance dialysis therapy. Because these difficulties are well known precise diagnoses of CAD examining symptoms in the thorax, electrocardiograms, and aggressive screening for CAD should be performed within 1-2 months after initiation of dialysis regardless of whether CAD is suspected or not, as recommended in DOQI guidelines. Although coronary revascularization such as PCI or CABG should be considered for dialysis patients with acute coronary syndrome and severe coronary artery disease, it is also important that beta-blockers, anti-platelet drugs, ACE-I/ARBs, and nitrates should be administered for dialysis patients with stable coronary heart disease. |